Harrington Investments, Inc Pfizer Inc Transaction History

Harrington Investments, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	BUY	$45.75 - $56.69 $8,555 - $10,601	187 Added 5.01%	3,922 $203,000
Q4 2021 Jan 21, 2022	BUY	$41.32 - $61.25 $154,330 - $228,768	3,735 New	3,735 $221,000
Q4 2018 Feb 01, 2019	SELL	$38.47 - $43.86 $172,422 - $196,580	-4,482 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$34.47 - $41.81 $206 - $250	6 Added 0.13%	4,482 $198,000
Q2 2018 Oct 19, 2018	SELL	$32.98 - $35.16 $25,988 - $27,706	-788 Reduced 14.97%	4,476 $162,000
Q1 2018 Apr 12, 2018	SELL	$31.91 - $37.02 $25,304 - $29,356	-793 Reduced 13.09%	5,264 $187,000
Q4 2017 Feb 01, 2018	BUY	$33.26 - $35.29 $201,455 - $213,751	6,057	6,057 $219,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Harrington Investments, Inc, based on Form 13F filings with the SEC.

Stay updated on Harrington Investments, Inc with notifications on news.